Edition:
United States

Santhera Pharmaceuticals Holding AG (SANN.S)

SANN.S on Swiss Exchange

31.00CHF
14 Dec 2017
Change (% chg)

CHF3.20 (+11.51%)
Prev Close
CHF27.80
Open
CHF28.55
Day's High
CHF31.50
Day's Low
CHF28.20
Volume
166,647
Avg. Vol
65,655
52-wk High
CHF82.00
52-wk Low
CHF25.10

Select another date:

Fri, Sep 15 2017

BRIEF-Santhera: negative opinion from the CHMP for Raxone in DMD

* SANTHERA RECEIVES NEGATIVE OPINION FROM THE CHMP FOR ITS MARKETING AUTHORIZATION APPLICATION FOR RAXONE® IN DMD AND INTENDS TO APPEAL THIS OPINION

BRIEF-Santhera Pharmaceuticals Holding H1 net loss widens to CHF 22.7 million

* ‍1H 2017 SALES OF CHF 10.9 MILLION, INCREASE OF 51% COMPARED TO 1H 2016​

BRIEF-Santhera announces approval of Raxone for LHON in Israel

* SANTHERA ANNOUNCES APPROVAL OF RAXONE FOR LHON IN ISRAEL Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Santhera's Raxone receives first positive EAMS scientific opinion from UK's MHRA in Duchenne muscular dystrophy

* SANTHERA'S RAXONE RECEIVES FIRST POSITIVE EAMS SCIENTIFIC OPINION FROM UK'S MHRA IN DUCHENNE MUSCULAR DYSTROPHY Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Select another date: